Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: An NRG Oncology Group study

Dana Chase, Helen Q. Huang, Bradley J. Monk, Lois Michelle Ramondetta, Richard T. Penson, Karen Gil, Lisa M. Landrum, Mario Leitao, Ana Oaknin, Warner K. Huh, Heather L. Pulaski, Katina Robison, Saketh R. Guntupalli, Debra Richardson, Ritu Salani, Michael W. Sill, Lari B. Wenzel, Krishnansu Sujata Tewari